STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands
NCT04470921 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2024-01-26
Summary
The aim of this study is to optimize implementation of the opportunistic salpingectomy throughout the Netherlands.
Conditions
- Risk Reduction
- Ovarian Cancer
Interventions
- PROCEDURE
-
Opportunistic Salpingectomy
An opportunistic salpingectomy refers to removal of the fallopian tubes without the ovaries during (laparoscopic) interventions for benign (gynaecological) disease to reduce the number of ovarian cancer cases.
Sponsors & Collaborators
-
Catharina Ziekenhuis Eindhoven
collaborator OTHER -
Radboud University Medical Center
lead OTHER
Principal Investigators
-
Joanne A de Hullu, MD, PhD · University Medical Center Nijmegen
-
Jurgen MJ Piek, MD, PhD · Catharina Ziekenhuis Eindhoven
-
Rosella PM Hermens, PhD · Scietific Institute for Quality of Healthcare, UMC Nijmegen
Eligibility
- Min Age
- 30 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-01
- Primary Completion
- 2025-01-01
- Completion
- 2025-12-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT00075712 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
NCT05287451 ·Status: RECRUITING ·Phase: NA
-
Trial on Radical Upfront Surgery in Advanced Ovarian Cancer
NCT02828618 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT01670799 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers
NCT04795596 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NCT04251052 ·Status: RECRUITING ·Phase: NA
-
Clinical Impact of Dedicated MR Staging of Ovarian Cancer
NCT03399344 ·Status: UNKNOWN ·Phase: NA
-
Minimally Invasive Interval Debulking Surgery in Advanced Ovarian Cancer
NCT07031908 ·Status: NOT_YET_RECRUITING
-
Role of Surgery in Advanced Ovarian Cancer
NCT03980028 ·Status: COMPLETED
-
HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy
NCT03275194 ·Status: RECRUITING ·Phase: PHASE2
-
Lymphadenectomy In Ovarian Neoplasms
NCT00712218 ·Status: COMPLETED ·Phase: NA
-
Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
NCT00003636 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer
NCT02312661 ·Status: COMPLETED ·Phase: PHASE1
-
Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
NCT00002538 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Quality of Care for Patients With Recurrent Ovarian Cancer
NCT02809339 ·Status: UNKNOWN
-
Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer
NCT06907771 ·Status: RECRUITING
-
Hyperthermic Intraperitoneal Chemotherapy for Treatment of Relapsed Ovarian Cancer
NCT03717610 ·Status: UNKNOWN ·Phase: NA
-
Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer
NCT00426257 ·Status: COMPLETED ·Phase: PHASE3
-
Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
NCT01970722 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Long Term Survivors in Ovarian Cancer
NCT03128294 ·Status: TERMINATED
-
Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
NCT01218490 ·Status: SUSPENDED ·Phase: PHASE3
-
OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study
NCT06611072 ·Status: RECRUITING ·Phase: NA
-
Intra-peritoneal Chemotherapy in Ovarian Cancer
NCT02861872 ·Status: UNKNOWN
-
Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase
NCT05731661 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer
NCT00610714 ·Status: COMPLETED ·Phase: PHASE2